PURE Insurance Upgrades to Duck Creek Billing for Enhanced Billing Automation
PURE Insurance upgrades to Duck Creek Billing, enhancing automation, customization, and operational efficiency in insurance billing for P&C carriers.
PURE Insurance upgrades to Duck Creek Billing, enhancing automation, customization, and operational efficiency in insurance billing for P&C carriers.
Colorado residents may see health insurance premiums rise up to 196% as expiring tax credits end, impacting affordability and increasing out-of-pocket costs. Regulatory reviews underway.
Nevada and Colorado announce notable health insurance premium hikes for individual and small group markets in 2026, driven by federal tax changes and new state programs like Nevada's Battle Born State Plans.
Explore the structural challenges of employer-sponsored health insurance in the U.S. through Venus Williams' case, highlighting disparities, labor market impacts, and policy implications.
Maine health insurers have requested rate increases from 8.4% to 32.7% affecting over 115,000 policyholders in the merged individual and small group market. A public forum on Aug 15 will discuss key drivers and regulatory review of these increases.
Homeowners insurance premiums in the U.S. have risen 9.3% since 2024, driven by climate risks and increased deductibles, challenging affordability and complicating mortgage closings. The E&S market grows in catastrophe-prone states.
Explore Mississippi's ongoing efforts to strengthen building codes and insurance market accountability two decades after Hurricane Katrina, highlighting regulatory challenges and mitigation funding developments.
A class action lawsuit alleges Allianz Life Insurance exposed sensitive data of 1.4 million customers in a July 2025 breach, raising cybersecurity and compliance concerns.
Medicaid cuts could reduce U.S. economic output by $183 billion and cost 408,000 jobs by 2034, with severe impacts on rural hospitals and healthcare access.
Study reveals limited insurance coverage for multiple sclerosis drugs increases relapse risk, highlighting Medicare plan disparities and formulary restrictions.